Temporal evolution of tumefactive neurolymphomatosis with serial MRI and positron emission tomography: illustrative case Authors: Ken Porche, Kimberly K Amrami, Robert J Spinner Published: 2026 ABSTRACT AbstractBACKGROUNDNeurolymphomatosis (NL), characterized by lymphoma infiltration of peripheral nerves, can be diagnostically challenging because of nonspecific clinical presentations and imaging findings. Tumefactive NL refers to circumferential subparaneurial tumor deposition beneath the paraneurium, outside the epineurium, producing an “encased” nerve appearance on MRI and at surgery.OBSERVATIONSA 76‑year‑old man with treated large B‑cell lymphoma developed a painful left lower trunk brachial plexopathy with numbness of the ring and little fingers and progressive weakness in finger flexors and intrinsic hand muscles. Serial brachial plexus MRI and 18F-fluorodeoxyglucose positron emission tomography over 4 months demonstrated evolution from a thin, circumferential subparaneurial rim of enhancement with mild nerve enlargement to a homogeneously enhancing, tumefactive lesion of the C8 nerve root and lower trunk. Targeted fascicular biopsy of a nonfunctioning C8 fascicle confirmed recurrent B‑cell lymphoma.LESSONSThis case illustrates temporal evolution along the tumefactive NL spectrum, from early, subtle subparaneurial involvement to a frankly tumefactive lesion. Recognizing this early MRI pattern, particularly in patients with a history of lymphoma and focal plexopathy, can guide targeted biopsy and facilitate earlier diagnosis and treatment. The clinicoradiological findings suggest that subtle peripheral/subparaneurial enhancement may precede overt tumefactive enlargement. https://thejns.org/doi/10.3171/CASE26139 Keywords: neurolymphomatosis, brachial plexus, magnetic resonance imaging, positron emission tomography, peripheral nerves, lymphoma, large B cell, diffuseABBREVIATIONS: CMAP = compound muscle action potential, FDG-PET= 18F-fluorodeoxyglucose positron emission tomography, MRC = Medical Research Council, NCS = nerve conduction study, NL = neurolymphomatosis Neurolymphomatosis (NL) is the infiltration of peripheral nerves by lymphoma; it is a rare and often misdiagnosed condition.1–3 Its rarity and diverse presentations frequently lead to delayed diagnosis and suboptimal outcomes.1,4,5 MRI typically shows diffuse or nodular nerve enlargement with T2 hyperintensity and contrast enhancement.2,5 More recently, a distinctive tumefactive appearance of NL has been recognized, in which lymphoma deposits circumferentially around the nerve’s epineurium in the subparaneurial space, producing an “encased” or cuffed nerve on MRI and at surgery.6–9 These subparaneurial tumors emphasize the importance of the paraneurium (circumneurium) as a route of tumor spread and as a potential early site of disease. However, the temporal evolution from early subtle imaging findings to a fully tumefactive, subparaneurial lesion has not been documented. We describe a single illustrative case of brachial plexus NL in which serial brachial plexus MRI and 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) were performed prior to targeted fascicular biopsy. These studies capture the evolution from relatively subtle, peripheral enhancement with only mild nerve enlargement to a frankly tumefactive subparaneurial lesion of the lower trunk. Correlating these sequential imaging findings with clinical localization and surgical pathology provides further insight into the spectrum of tumefactive NL and highlights opportunities for earlier diagnosis. With institutional review board approval, we performed a retrospective review of our institutional NL case database to identify patients with suspected or confirmed NL who had serial, pretreatment MRI studies of the same anatomical region allowing assessment of interval radiographic evolution. Cases in the database were identified through institutional records and were considered confirmed when supported by tissue biopsy and/or CSF cytology in the appropriate clinical context. We screened available imaging to find examples demonstrating evolution from an early, predominantly circumferential/peripheral pattern of enhancement to a more diffuse/tumefactive enhancing lesion prior to initiation of therapy. Of 162 suspected NL cases (including 78 biopsy- or CSF-confirmed cases) reviewed, 1 patient had two high-quality MRI examinations before treatment that clearly demonstrated progression from a thin, circumferential enhancing rim to homogeneous tumefactive enhancement. Clinical records and imaging were reviewed to summarize presentation, electrodiagnostic localization, imaging chronology (MRI and FDG-PET when available), and pathological confirmation. Illustrative Case A 76-year-old man with a history of large B-cell lymphoma (treated with six cycles of rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone 2 years earlier) and well-controlled type 2 diabetes mellitus developed numbness of the left ring and little fingers over the past 6 months, which he first noticed while putting on gloves. Over about a week, the numbness spread proximally along the medial forearm and was followed by hand weakness over several days. The symptoms remained confined to the left upper limb and did not progress substantially over the ensuing months. On examination he had severe left lower trunk weakness. Proximal shoulder and elbow muscles were full strength (Medical Research Council [MRC] grade 5/5). Wrist extension was normal (MRC grade 5/5), and finger extension was only mildly weak (approximately MRC grade 4/5). In contrast, median- and ulnar-innervated hand muscles were markedly weak: the flexor pollicis longus was MRC grade 3+/5, the flexor digitorum profundus and flexor digitorum superficialis were about MRC grade 1/5, and the interossei showed severe weakness (MRC grade 1/5) with poor thenar and hypothenar function. He had visible atrophy and fasciculations in the intrinsic hand muscles and a clearly positive Wartenberg and Froment’s sign. Sensation to pinprick and light touch was reduced in the ulnar distribution of the hand and medial forearm, with loss of two-point discrimination in the ring and little fingers. Tinel’s sign was markedly positive in the supraclavicular fossa over the left lower trunk/C8 region. Nerve conduction studies (NCSs) showed markedly reduced compound muscle action potential (CMAP) amplitudes and slowing in the left median and ulnar nerves (abductor pollicis brevis 1.8 mV, abductor digiti minimi 1.9 mV; both below normal, with slowed conduction velocities and prolonged distal latencies), with absent left ulnar sensory responses and low-amplitude median sensory responses bilaterally. The sural sensory nerve action potential was reduced, and the left peroneal CMAP was low with borderline slowing, indicating a mild generalized length-dependent sensorimotor polyneuropathy. Needle electromyography demonstrated fibrillation potentials and chronic neurogenic motor unit potentials with reduced recruitment in the left first dorsal interosseous and other C8–T1-innervated hand muscles, with milder chronic changes in more proximal left upper limb muscles and distal lower limb muscles. The study was interpreted as a left upper limb radiculoplexus neuropathy affecting the lower trunk, superimposed on a generalized diabetic sensorimotor peripheral neuropathy; lymphoma-related plexopathy could not be excluded. A subsequent limited NCS showed an absent medial antebrachial cutaneous sensory response on one side, consistent with a postganglionic lower trunk/medial cord process. CSF studies revealed only mild elevation of protein 53 mg/dl (normal range 0–35 mg/dl) without any malignant cells on cytology. Initial imaging studies at his outside hospital included a 1.5T MRI study of the brachial plexus, obtained approximately 4 months before biopsy, which showed mild enlargement of the left C8 and T1 nerve roots with a thin, circumferential rim of contrast enhancement surrounding the lower trunk without a discrete mass (Fig. 1). FDG-PET performed 1 month later was initially interpreted as normal; however, on our reinterpretation, it showed corresponding mild linear hypermetabolism along the C8 nerve root without definite T1 uptake. Repeat 3T MRI and FDG-PET performed at our facility 4 months after the initial scan and 2 weeks before surgery showed progression from a thin, circumferential rim of enhancement along the nerve to diffuse, homogeneous, tumefactive intraneural enhancement with nerve enlargement, as well as increased, qualitatively moderate FDG uptake along the same segment (Fig. 2). Serial MR images of the brachial plexus (obtained 4 months apart). A: Sagittal postcontrast T1-weighted image demonstrating thin rim enhancement of the C8 (double arrows) and T1 (arrowhead) nerve roots; both have mild enlargement. B: Sagittal postcontrast spoiled gradient echo image demonstrating homogeneous enhancement of the C8 (double arrows) and T1 (arrowhead) nerve roots, with interval progression to a tumefactive/enlarged appearance of the C8 root. Serial FDG-PET scans of the brachial plexus (obtained 3 months apart). A: Coronal FDG-PET scan demonstrating mild linear FDG uptake along the C8 nerve. This scan was obtained 1 month after the MR image shown in Fig. 1A. B: Coronal FDG-PET scan demonstrating increased linear FDG uptake along the C8 nerve, qualitatively moderate in intensity. This scan was obtained the same day as the MR image shown in Fig. 1B. The insets magnify the regions of interest. The double arrows indicate mild linear uptake and the single arrowhead increased uptake. Given the focal, progressive lower trunk weakness and pain, concordant electrodiagnostic and imaging localization, negative CSF studies, a negative CT-guided biopsy of a scapular lesion (at an outside facility), and the history of large B-cell lymphoma, he underwent a planned targeted fascicular biopsy of the C8 component of the lower trunk. Intraoperatively, the lower trunk and C8 root were significantly enlarged and nodular, whereas T1 appeared relatively small and uninvolved. A nonfunctioning C8 fascicle was identified using intraoperative stimulation and submitted for biopsy (Fig. 3). Frozen-section analysis suggested lymphoma, and permanent pathological analysis confirmed B-cell lymphoma infiltrating the nerve fascicle, establishing the diagnosis of NL. Because only a targeted fascicular biopsy was obtained, the specimen confirmed intrafascicular recurrent B-cell lymphoma, but paraneurial/subparaneurial involvement could not be directly assessed. A: Intraoperative view of the left brachial plexus demonstrating enlargement and nodularity of the lower trunk (LT) and C8 root compared with the upper trunk (UT) and middle trunk (MT). The subclavian artery (SA) is seen inferior to the plexus. B: Gross specimen of the targeted C8 fascicular biopsy. TC = thyrocervical trunk. Informed Consent The necessary informed consent was obtained in this study. Discussion Observations This case highlights that tumefactive NL represents a spectrum rather than a single static imaging pattern. We previously introduced the term “tumefactive NL” to describe cases in which lymphoma produces a large, mass‑like enlargement of a peripheral nerve or plexus.6,7 Subsequent work has shown that this tumefactive appearance can be produced by variable combinations of intraneural and subparaneurial tumor, including more occult disease in which the nerve is encased by a relatively thin subparaneurial cuff of tumor rather than a bulky mass.8,9 Most radiological series of NL have emphasized more obvious findings such as fusiform nerve enlargement, T2 hyperintensity, and nodular or diffuse contrast enhancement.2,4,10,11 Murthy et al. proposed a unifying “crescendo-decrescendo” model of NL spread, from initial intraneural accumulation of tumor cells, to extrusion at sites of relative weakness (such as branch points), and finally expansion into the paraneurial space.6 Our case adds temporal support to this model: early imaging showed only mild enlargement of the C8–T1 roots with a thin, circumferential rim of enhancement, while follow‑up imaging 4 months later demonstrated a frankly tumefactive, homogeneously enhancing lesion of the lower trunk. This imaging evolution is compatible with a shift from predominantly peripheral/subparaneurial enhancement to more diffuse intraneural involvement as disease progresses. In this context, we interpret the early peripheral enhancement as tumor concentrated within the subparaneurial space (beneath the paraneurium and outside the epineurium) forming a sleeve of lymphoma around the nerve. Barone et al. emphasized the critical importance of this subparaneurial compartment, demonstrating that lymphoma can encase nerve fascicles and produce a characteristic “encased nerve” appearance on MRI with direct intraoperative and fluorescein confirmation.8 The present case likely reflects a similar process at an earlier time point, before the subparaneurial tumor and endoneurial infiltration coalesce into a single enlarged, homogeneously enhancing mass. Pathological series of NL have shown that lymphoma can involve any nerve compartment, including the endoneurium and epineurium as well as the perineurium surrounding individual fascicles.12–14 We have previously demonstrated the histopathology of NL contained within the subparaneurial compartment.7,8 This subparaneurial compartment appears to be a path of relatively low resistance that allows longitudinal spread of tumor along the nerve’s surface.6,9,12 From a therapeutic standpoint, recognizing subparaneurial spread has several implications. First, identifying a thin, circumferential rim of enhancement around a clinically symptomatic nerve or plexus in a patient with known or suspected lymphoma should raise concern for early NL even when overall nerve caliber is only mildly increased. Second, awareness of the subparaneurial compartment as a route of spread may influence radiation planning or the use of regional therapies, particularly when there is contiguous CNS involvement. Finally, correlating these subtle imaging findings with careful clinical localization may enable earlier diagnosis and treatment, as in this case, which prompted a targeted fascicular biopsy of the C8 component of the lower trunk. The principal limitation of this report is that it describes a single patient in whom sequential pretreatment imaging was available. This likely reflects both the rarity of NL and the fact that most patients undergo imaging only once before therapy. Nonetheless, documenting this temporal evolution provides an additional piece of evidence that tumefactive NL is part of a broader spectrum of subparaneurial and intraneural lymphoma involvement. Although our biopsy was limited to a nonfunctioning fascicle and did not directly sample the subparaneurial space, the evolution of the imaging findings and the correspondence with prior surgical series strongly suggest that early tumor was present subparaneurially as well as intraneurally in this case. Lessons A thin, circumferential rim of contrast enhancement around a nerve or plexus on MRI can represent early lymphomatous spread within the subparaneurial compartment and may precede frank tumefactive enlargement or severe neurological dysfunction. In patients with known or suspected lymphoma and focal symptoms, recognizing this pattern, together with concordant FDG‑PET uptake and careful neurological localization, can prompt timely, targeted fascicular biopsy and earlier initiation of therapy. Awareness of this subtle but specific appearance expands the spectrum of recognized imaging features in tumefactive NL and may help prevent delays in diagnosis. Disclosures The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper. Author Contributions Conception and design: all authors. Acquisition of data: all authors. Analysis and interpretation of data: all authors. Drafting the article: all authors. Critically revising the article: all authors. Reviewed submitted version of manuscript: all authors. Approved the final version of the manuscript on behalf of all authors: Porche. Administrative/technical/material support: Porche, Spinner. Study supervision: Amrami, Spinner. Correspondence Ken Porche: Mayo Clinic Arizona, Phoenix, AZ. porche.ken@mayo.edu. References